White House Flips Out Over Report Trump May Be on Weight Loss Drug

The White House erupted in denial and criticism after a report suggested President Trump might have received early access to a new weight loss drug called retatrutide. White House spokesperson Kush Desai vehemently refuted the claim and attacked the media outlet, STAT, for even suggesting such a possibility. This incident underscores the ongoing tension between the administration and the press, highlighting how sensitive political figures can react to speculative media reports, regardless of their veracity. The controversy serves as a reminder of the intense scrutiny surrounding the president's personal health and decisions.